HGHRX
$43.64
+0.28 (+0.65%)
NAV as of Sep 01, 2026
Performance
- 1 Month
- +5.8%
- 3 Months
- +16.7%
- YTD
- +10.7%
- 1 Year
- +32.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 16.0%
- Largest decline max drawdown, since Aug 2025
- -10.9%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.85
Own HGHRX?
See how HGHRX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.